Fairfax, VA, United States of America

Drew Weissman

This inventor holds 1 USPTO granted patent. Top assignee: George Mason Research Foundation, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Drew Weissman. Retrieved from https://idiyas.com/inventor/drew-weissman-iuvcx8l9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Drew Weissman: Innovator in Lipid Technology

Introduction

Drew Weissman is a prominent inventor based in Fairfax, VA (US). He is known for his significant contributions to the field of lipid technology, particularly in the development of ionizable lipids.

Latest Patents

Weissman holds a patent titled "Ionizable Lipids and Methods of Manufacture and Use Thereof." This patent represents a crucial advancement in the manufacturing and application of lipids, which are essential in various biomedical applications.

Career Highlights

Drew Weissman is affiliated with the George Mason Research Foundation, Inc., where he continues to innovate and contribute to scientific research. His work has had a profound impact on the field of biotechnology.

Collaborations

Throughout his career, Weissman has collaborated with notable colleagues, including Michael Daro Buschmann and Mikell Paige. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Drew Weissman is a key figure in the advancement of lipid technology, with a focus on innovative solutions that have the potential to transform biomedical applications. His contributions continue to shape the future of this important field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…